Premium
Tenaya Therapeutics Inc (TNYA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2... Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -4.16666666667 | 0.72 | 0.74 | 0.6506 | 2759220 | 0.70387909 | CS |
| 4 | -0.08 | -10.3896103896 | 0.77 | 0.9478 | 0.6506 | 3278080 | 0.76080349 | CS |
| 12 | 0.0628 | 10.012755102 | 0.6272 | 1.15 | 0.6272 | 3781591 | 0.7990688 | CS |
| 26 | -0.02125 | -2.98769771529 | 0.71125 | 1.15 | 0.5316 | 4054373 | 0.78074253 | CS |
| 52 | 0.1036 | 17.6671214188 | 0.5864 | 2.28 | 0.5316 | 4050978 | 0.98970737 | CS |
| 156 | -5.11 | -88.1034482759 | 5.8 | 7.01 | 0.36 | 2370004 | 1.34691906 | CS |
| 260 | -18.81 | -96.4615384615 | 19.5 | 32 | 0.36 | 1552671 | 1.78326016 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
